The purpose of this work was to assess whether a single intracavernous injection (ICI) of a low dose of the combination of papaverine ± phentolamine is replaceable by a high dose of the oral erectogenic agent sildena®l as mode of stimulation during pharmaco-penile duplex ultrasonography (PPDU). Eleven patients with complaints of erectile dysfunction were included in a crossover study. With an interval of two weeks the patients were exposed to ICI with papaverineaphentolamine (3.75 mga0.125 mg) and oral administration with sildena®l (100 mg) preceding PPDU. Five patients started with ICI. Six patients started with sildena®l. In the sildena®l stimulation mode, visual erotic stimulation (VES) was used to initiate erection. VES was applied by personal LCD monitor. Cut-off values to de®ne suf®cient arterial response were: peak¯ow velocity (PSV) b 25 cmas and acceleration time (AT)`72 ms. Cut-off value to de®ne suf®cient venoocclusion was a resistance index ! 1.00. Statistical analysis of PPDU parameters shows no signi®cant difference between the two modes of stimulation for arterial response (PSV, AT), whereas the resistance index, as a parameter of veno-occlusive response was signi®cantly higher in the sildena®l mode. This ®nding is con®rmed in the clinical translation of the results: two patients with an insuf®cient arterial response to ICI had a suf®cient arterial response to sildena®l and only one patient showed an insuf®cient arterial response following sildena®l, whereas the response following ICI was suf®cient. Analysis of veno-occlusive responses shows remarkable differences between both modes of stimulation. Whereas following the administration of sildena®l all veno-occlusive responses were classi®ed as suf®cient, seven patients showed an insuf®cient veno-occlusive response following ICI. As mode of stimulation in PPDU, high dose sildena®l yields signi®cantly less false positive diagnoses of`veno-occlusive dysfunction' than intracavernous injection of the combination papaverineaphentolamine. No difference was found in the quality of the arterial response. Based on this study we conclude that sildena®l may replace ICI as mode of stimulation during PPDU.
Introduction
Although vascular factors may be found in approximately 80% of men with erectile dysfunction (ED), 1 it has not yet been possible to develop an ideal vascular diagnostic test to assess this abnormality accurately in men with ED. Since 1985, pharmaco-penile duplex ultrasonography (PPDU) is considered the`gold standard' to study penile hemodynamics. 2 Over the last decade, improvement of ultrasound technology and the increase of computer power has led to a continuous improvement of Doppler techniques, resulting in a more reliable outcome for almost all elements in vascular diagnostic tests. However, these technical improvements have not eliminated the invasive part of PPDU; the intracavernous injection (ICI) of a vasoactive agent to initiate erection. The disadvantage of ICI is its invasiveness causing discomfort and anxiety in the patient, resulting in veno-occlusive dysfunction and the risk of inducing ®brosis and priapism. 3 With the advent of the effective oral erectogenic agent sildena®l, we investigated whether the traditional mode of pharmacological stimulation in PPDU (a low dose ICI with papaverinea phentolamine) could be replaced by a high dose of oral sildena®l. age was 50.4 y (range 28 ± 78). All patients signed a written informed consent before entering the study. Patients with contra-indications for sildena®l were excluded.
All patients underwent PPDU twice, with an interval of 2 weeks, using a different mode of pharmacological stimulation at each occasion. Five patients started with an intracavernous injection (ICI) of the combination of papaverinea phentolamine (Androskat 1 ) (3.75 mga0.125 mg); the other six patients started with oral administration of 100 mg sildena®l (Viagra 1 ). In the ICI mode, PPDU was started immediately following intracavernous injection (Figure 1 ). In the sildena®l mode, PPDU was performed 1 h after administration, considering the fact that the peak plasma concentration of sildena®l occurs approximately at that time. Moreover, visual erotic stimulation (VES) was added to initiate erection. 4 Using an ATL HDI 1 5000 CV Duplex scanner, PPDU was performed as described by Meuleman et al. 5 To assess arterial response we used peak¯ow velocity (PSV) and acceleration time (AT). To assess veno-occlusive response resistance index (RI) was calculated. Cut-off values to de®ne arterial suf®-ciency were a PSV of b 25 cmas and an AT of 72 ms. Veno-occlusive suf®ciency was determined as a RI equal or higher than 1.0.
VES consisted of erotic fragments of 10 min, picturing two women and one man engaged in different sexual activities, including fellatio, cunnilingus and penile intermission. To optimise the privacy of the patient, the fragments were shown with the use of special glasses: Personal LCD Monitor (PC-Glasstron TM PLM-S700E, Sony Japan). All patients were asked to contact the hospital in case of an erection lasting more than 6 h following the investigation.
Statistical analysis of results was based on the non-parametric test of Friedman for paired samples.
Results
The mean hemodynamic effects after two different modes of stimulation are shown in Table 1 . No statistical signi®cant difference is found for the parameters of the arterial response (PSV, P 0.37; AT, P 0.48). The veno-occlusive response, as determined by RI was signi®cantly better (P 0.002) following stimulation with sildena®l.
The clinical classi®cation of responses are shown in Tables 2 and 3 .
The arterial response after ICI was insuf®cient in six patients and suf®cient in ®ve patients. The arterial response after sildena®l was insuf®cient in ®ve patients and suf®cient in six patients. In three patients the diagnosis was different between the two modes of stimulation. The veno-occlusive response Figure 1 Schematic representation of the study. Top line represents PPDU using oral sildena®l in combination with VES and lowering represents PPDU using ICI of papaverineaphentolamine. 
Discussion
To date, there is a scarcity of data concerning the use of sildena®l as vasodilatory agent during PPDU. 6 We investigated whether a low dose ICI with papaverineaphentolamine can be replaced by a high dose of sildena®l as mode of stimulation during PPDU. With regard to the arterial response we found no statistical difference between the two modes of stimulation. The clinical diagnosis with regard to arterial response was different in 3a11 patients between the two modes of stimulation. It is remarkable that an insuf®cient arterial response following ICI changed into a suf®cient response following oral pharmacological stimulation in two patients. These results are comparable with the literature, 6 and may re¯ect the lack of reproducibility of PPDU rather than a distinct difference of vasodilatory effectiveness of the two modes of stimulation. In our opinion therefore, the conclusion is justi®ed that a single low-dose intracavernous stimulation is replaceable by a high-dose of sildena®l in the assessment of the cavernosal arterial response.
With regard to veno-occlusive response, our data show remarkable differences between the ICI and sildena®l mode. Whereas, following the administration of sildena®l all veno-occlusive responses are classi®ed as suf®cient, the majority of patients show an insuf®cient veno-occlusive response following ICI. This ®nding can not be attributed to a greater pharmacological effectiveness of sildena®l to induce cavernous smooth muscle relaxation, but is probably due to a lower level of anxiety in patients following oral stimulation. Moreover, the addition of visual erotic stimulation as an initiator of erection may have played a decisive role in a more complete cavernous smooth muscle relaxation in the sildena®l mode. Why than are these differences not noted with regard to arterial response? The most plausible explanation is that anxiety has a greater negative impact on the veno-occlusive mechanism than on the arterial response, due to a higher sensitivity of the latter to adrenergic input. 7 On basis of this pilot study, we conclude that a high dose of sildena®l may replace a single low dose ICI of the combination of papaverineaphentolamine as mode of stimulation during pharmaco-penile duplex scanning, yielding less false positive diagnoses of veno-occlusive dysfunction. The disadvantage of using sildena®l as mode of stimulation is the fact that the stimulation protocol is laborious and time-consuming because visual erotic stimulation has to be provided and the patient has to be dosed 1 h before PPDU. Sildena®l in pharmaco-penile duplex ultrasonography TGW Speel et al
